A burgeoning field is launching its first clinical trial to find out whether dialing back cell development can safely refresh ...
A Survival God for the Age of Abundance,” Peter H. Diamandis and Steven Kotler explore what it means to be human in a world ...
From billionaire-backed biotech to promising animal studies, this early trial will test whether partial reprogramming can ...
Dr. Lun Yu explains how advanced molecular design can enable peptides to target the biological roots of skin ageing, turning longevity science into actionable innovation ...
Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced data from an investigator-initiated Phase II trial at Memorial Sloan Kettering Cancer Center, investigating ...
Researchers at Oregon Health & Science University have uncovered a key reason why immunotherapy has largely failed in ...
The capacity of an organism to regenerate depends on cell dedifferentiation followed by proliferation. Mammals, in general, have limited regenerative capacity. Now, a team of researchers at the Salk ...
Systemic candidiasis is an opportunistic fungal infection that has been difficult to treat effectively. Research published in a paper in the April edition of Cell Host & Microbe suggests that immune ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results